UC Irvine Health
Videos
Insights from 2024 EHA Annual Meeting
EHA 2024 Insights: Advantages of Using Venetoclax-Based Therapy in High-Risk CLL
FEATURING
Catherine Coombs
- 51 views
- June 28, 2024
- 1
UC Irvine Health
Fixed-Duration Treatment in CLL: Current Considerations
FEATURING
Elizabeth Brem
- 660 views
- November 20, 2023
- 2
UC Irvine Health
GU Treatment Updates: Standard of Care 5-Year Follow-Up Data From the VESPER Trial in MIBC
FEATURING
Nataliya Mar
- 114 views
- September 8, 2023
- 1
UC Irvine Health
GU Treatment Updates: mCRPC Therapy Options and Clinical Applications of PROPEL & TALAPRO-2 Studies
FEATURING
Nataliya Mar
- 117 views
- September 6, 2023
Insights from 2023 EHA® Annual Meeting
Experts Discuss Key Updates in CLL From EHA and iCML
FEATURING
Susan O'Brien,
Catherine Coombs
- 440 views
- August 3, 2023
- 3
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Experts Discuss Key Abstracts in CLL"
FEATURING
Susan O'Brien,
Catherine Coombs
- 2,013 views
- June 15, 2023
- 6
UC Irvine Health
S1918: Randomized Phase 2/3 Study of R-miniCHOP +/- Oral Azacitidine (CC-486) in Elderly Patients With 1L DLBCL
FEATURING
Elizabeth Brem
- 219 views
- May 26, 2023
- 2
UC Irvine Health
Molecular Characteristics of Advanced ccRCC Harboring TERT Mutations
FEATURING
Nataliya Mar
- 71 views
- May 2, 2023
Indy Hematology Review
Recent Updates on the Treatment of Polycythemia Vera
FEATURING
Angela Fleischman
- 361 views
- April 18, 2023
Indy Hematology Review
Updates on the Treatment of Myelofibrosis and FGFR-Mutated Myeloid Neoplasms
FEATURING
Angela Fleischman
- 219 views
- April 18, 2023
UC Irvine Health
Work-Up and Prescribing Patterns in Real World Management of Patients With mCSPC
FEATURING
Nataliya Mar
- 66 views
- August 1, 2022
- 1